News
AstraZeneca PLC released its flu vaccine nasal spray for at-home use on Friday, an option that comes at a contentious time ...
FluMist is the only nasal vaccine approved in the U.S. It’s administered as two spritzes—one in each nostril—and stimulates ...
AstraZeneca (LSE:AZN) recently launched "FluMist Home," an at-home flu vaccine delivery service, marking an important ...
FluMist has been approved since 2003, but, until last year, only for administration by a healthcare practitioner. The new nod ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results